These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23647536)

  • 1. Editorial (hot topic: using cheminformatics for drug and target discovery in medicinal chemistry).
    Zhong WZ
    Curr Top Med Chem; 2013; 13(10):1139-40. PubMed ID: 23647536
    [No Abstract]   [Full Text] [Related]  

  • 2. Computational prediction of drug-target interactions in medicinal chemistry.
    González-Díaz H
    Curr Top Med Chem; 2013; 13(14):1619-21. PubMed ID: 23889056
    [No Abstract]   [Full Text] [Related]  

  • 3. Project ranks billions of drug interactions.
    Reardon S
    Nature; 2013 Nov; 503(7477):449-50. PubMed ID: 24284710
    [No Abstract]   [Full Text] [Related]  

  • 4. Backtranslating clinical knowledge for use in cheminformatics--what is the potential?
    Scheiber J
    Bioorg Med Chem; 2012 Sep; 20(18):5461-3. PubMed ID: 22626549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of structural biology in drug discovery.
    Tari LW
    Methods Mol Biol; 2012; 841():1-27. PubMed ID: 22222446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2018 Jul; 23(7):1396-1406. PubMed ID: 29574212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpine drug discovery summit: 10th Swiss Course on Medicinal Chemistry.
    Müller G; Ernst B
    ChemMedChem; 2012 Dec; 7(12):2237-40. PubMed ID: 23180615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of drug discovery and development.
    Ator MA; Mallamo JP; Williams M
    Curr Protoc Pharmacol; 2006 Dec; Chapter 9():Unit9.9. PubMed ID: 22294181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: From Chemoinformatics to Nanoinformatics: New Tools for Drug Discovery and Nanoparticles Design in Medicinal Chemistry.
    Toropov AA; Toropova AP
    Curr Top Med Chem; 2015; 15(18):1767. PubMed ID: 25961529
    [No Abstract]   [Full Text] [Related]  

  • 11. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
    Griffen EJ; Dossetter AG; Leach AG; Montague S
    Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists.
    Raveglia LF; Giardina GA
    Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.
    Sheik Amamuddy O; Veldman W; Manyumwa C; Khairallah A; Agajanian S; Oluyemi O; Verkhivker G; Tastan Bishop O
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel worlds of public and commercial bioactive chemistry data.
    Lipinski CA; Litterman NK; Southan C; Williams AJ; Clark AM; Ekins S
    J Med Chem; 2015 Mar; 58(5):2068-76. PubMed ID: 25415348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-7.
    Gütschow M; Eynde JJV; Jampilek J; Kang C; Mangoni AA; Fossa P; Karaman R; Trabocchi A; Scott PJH; Reynisson J; Rapposelli S; Galdiero S; Winum JY; Brullo C; Prokai-Tatrai K; Sharma AK; Schapira M; Azuma YT; Cerchia L; Spetea M; Torri G; Collina S; Geronikaki A; García-Sosa AT; Vasconcelos MH; Sousa ME; Kosalec I; Tuccinardi T; Duarte IF; Salvador JAR; Bertinaria M; Pellecchia M; Amato J; Rastelli G; Gomes PAC; Guedes RC; Sabatier JM; Estévez-Braun A; Pagano B; Mangani S; Ragno R; Kokotos G; Brindisi M; González FV; Borges F; Miloso M; Rautio J; Muñoz-Torrero D
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32605268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the utility of molecular scaffolds for medicinal and computational chemistry.
    Bajorath J
    Future Med Chem; 2018 Jul; 10(14):1645-1648. PubMed ID: 29957045
    [No Abstract]   [Full Text] [Related]  

  • 17. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: computational chemogenomics in drug design and discovery.
    Bisson WH
    Curr Top Med Chem; 2012; 12(17):1867-8. PubMed ID: 23116465
    [No Abstract]   [Full Text] [Related]  

  • 19. Exploring activity cliffs in medicinal chemistry.
    Stumpfe D; Bajorath J
    J Med Chem; 2012 Apr; 55(7):2932-42. PubMed ID: 22236250
    [No Abstract]   [Full Text] [Related]  

  • 20. The Latest Researches of Enzyme Inhibition and Multi-Target Drug Predictors in Medicinal Chemistry.
    Zhou GP
    Med Chem; 2019; 15(6):572-573. PubMed ID: 31509103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.